尚荣医疗收盘下跌2.27%，滚动市盈率146.32倍，总市值32.72亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Shangrong Medical, indicating a significant disparity between its high PE ratio and the industry average [1][2] - As of July 14, Shangrong Medical's stock closed at 3.87 yuan, down 2.27%, with a rolling PE ratio of 146.32 times and a total market value of 3.272 billion yuan [1] - The average PE ratio for the medical device industry is 51.90 times, with a median of 37.22 times, placing Shangrong Medical at the 111th position in the industry ranking [1][2] Group 2 - For Q1 2025, the company reported an operating income of 280 million yuan, a year-on-year increase of 1.30%, and a net profit of 13.9642 million yuan, reflecting a year-on-year growth of 0.58% [2] - The sales gross margin for the company stands at 15.27% [2] - The company has a total of 58,323 shareholders as of March 31, 2025, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]